Our solutions and services
Supporting pharmaceutical companies with the challenges of digital engagement with HCPs
End-to-end management of your congress literature and assets - Resource Centre enables you to collate and share your digital scientific content to where it is needed: web portal, congress booth and virtual events.
Extending the reach of your clinical data - Nar8r enables authors to extend the reach of their research – enhancing their content by visually navigating and narrating to create a valuable video output.
Risks and consequences of not managing scientific content distribution
- Copyright infringement – we enable you to manage copyright and contract compliance
- Violation of publishers terms and conditions – we ensure you don’t fall foul of the open access traps
- Sunshine Act / EFPIA infringement – we can track every transfer of value and ensure adherence to the code
- Content procurement inefficiencies – we help you manage cost effectiveness
- GDPR compliance – we align with your company policy
However, we recognise that technology is only as good as the user and their engagement with digital solutions. With the use of digital content continuing to increase, our platform aligns seamlessly with existing solutions to deliver a simple user experience that remains familiar with the user.
With digital innovation at our heart, our solutions not only help our customers to build trust and confidence with clinicians but also ensure they can track and record every transfer of value when sharing ePrints, improve HCP and field force engagement, as well as extending the reach of their clinical data.
No other company provides this level of management and insight to support the distribution of scientific content.
HCP use of digital continues to evolve: COVID-19 has disrupted the go-to-market model in Pharma. In-person contacts have dropped dramatically and it’s now ‘digital first’.
Reach of pharma website services – US & EU4 + UK specialists
Across Health Navigator365™ Core research carried out in 2021, highlighted that on average the delivery of ePrints and other downloadable content, such as copyright peer-reviewed scientific publications, scores highest for HCPs in the EU4, UK and US. However, access to this content is limited, offering a significant opportunity for pharma to improve its reach.